blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3601612

EP3601612 - USE OF ARGININE AS AN ANTICOAGULANT IN THE POLYMERASE CHAIN REACTION [Right-click to bookmark this link]
Former [2020/06]USE OF ANTICOAGULANTS IN THE POLYMERASE CHAIN REACTION
[2021/25]
StatusNo opposition filed within time limit
Status updated on  01.07.2022
Database last updated on 19.10.2024
FormerThe patent has been granted
Status updated on  23.07.2021
FormerGrant of patent is intended
Status updated on  06.06.2021
FormerExamination is in progress
Status updated on  02.10.2020
FormerRequest for examination was made
Status updated on  03.01.2020
FormerThe international publication has been made
Status updated on  29.09.2018
Formerunknown
Status updated on  10.04.2018
Most recent event   Tooltip27.09.2024Lapse of the patent in a contracting state
New state(s): MT
published on 30.10.2024 [2024/44]
Applicant(s)For all designated states
Genedrive Diagnostics Ltd.
The Incubator Building
Grafton Street
Manchester
M13 9XX / GB
[2020/06]
Inventor(s)01 / AINSWORTH, Shaun
Incubator Building
Grafton Street
Manchester Greater Manchester M13 9XX / GB
02 / COBB, Ben
Incubator Building
Grafton Street
Manchester Greater Manchester M13 9XX / GB
03 / MIELE, Gino
Incubator Building
Grafton Street
Manchester Greater Manchester M13 9XX / GB
 [2020/06]
Representative(s)Williams, Gareth Owen
Marks & Clerk LLP
62-68 Hills Road
Cambridge CB2 1LA / GB
[2020/06]
Application number, filing date18714049.616.03.2018
[2020/06]
WO2018GB50683
Priority number, dateGB2017000440120.03.2017         Original published format: GB 201704401
[2020/06]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018172749
Date:27.09.2018
Language:EN
[2018/39]
Type: A1 Application with search report 
No.:EP3601612
Date:05.02.2020
Language:EN
The application published by WIPO in one of the EPO official languages on 27.09.2018 takes the place of the publication of the European patent application.
[2020/06]
Type: B1 Patent specification 
No.:EP3601612
Date:25.08.2021
Language:EN
[2021/34]
Search report(s)International search report - published on:EP27.09.2018
ClassificationIPC:C12Q1/686
[2020/06]
CPC:
C12Q1/686 (EP,US); C12Q1/6806 (EP,US); C12Q2527/125 (US)
C-Set:
C12Q1/6806, C12Q2527/125 (EP);
C12Q1/686, C12Q2527/125 (EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2020/06]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:VERWENDUNG VON ARGININ ALS ANTIKOAGULANT IN DER POLYMERASE-KETTENREAKTION[2021/25]
English:USE OF ARGININE AS AN ANTICOAGULANT IN THE POLYMERASE CHAIN REACTION[2021/25]
French:UTILISATION DE L'ARGININE COMME ANTICOAGULANT DANS LA RÉACTION EN CHAÎNE DE LA POLYMÉRASE[2021/25]
Former [2020/06]VERWENDUNG VON ANTIKOAGULANTIEN IN DER POLYMERASE-KETTENREAKTION
Former [2020/06]USE OF ANTICOAGULANTS IN THE POLYMERASE CHAIN REACTION
Former [2020/06]UTILISATION D'ANTICOAGULANTS DANS LA RÉACTION EN CHAÎNE DE LA POLYMÉRASE
Entry into regional phase01.07.2019National basic fee paid 
01.07.2019Designation fee(s) paid 
01.07.2019Examination fee paid 
Examination procedure01.07.2019Examination requested  [2020/06]
01.07.2019Date on which the examining division has become responsible
15.04.2020Amendment by applicant (claims and/or description)
06.10.2020Despatch of a communication from the examining division (Time limit: M04)
28.01.2021Reply to a communication from the examining division
07.06.2021Communication of intention to grant the patent
15.07.2021Fee for grant paid
15.07.2021Fee for publishing/printing paid
15.07.2021Receipt of the translation of the claim(s)
Opposition(s)27.05.2022No opposition filed within time limit [2022/31]
Fees paidRenewal fee
12.03.2020Renewal fee patent year 03
12.03.2021Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU16.03.2018
AL25.08.2021
AT25.08.2021
CY25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
IT25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
MK25.08.2021
MT25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
IE16.03.2022
LU16.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
[2024/44]
Former [2024/24]HU16.03.2018
AL25.08.2021
AT25.08.2021
CY25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
IT25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
MK25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
IE16.03.2022
LU16.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2024/23]AL25.08.2021
AT25.08.2021
CY25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
IT25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
MK25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
IE16.03.2022
LU16.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2024/20]AL25.08.2021
AT25.08.2021
CY25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
IT25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
IE16.03.2022
LU16.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2023/10]AL25.08.2021
AT25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
IT25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
IE16.03.2022
LU16.03.2022
BE31.03.2022
CH31.03.2022
LI31.03.2022
Former [2023/09]AL25.08.2021
AT25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
IT25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
IE16.03.2022
LU16.03.2022
CH31.03.2022
LI31.03.2022
Former [2023/08]AL25.08.2021
AT25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
IT25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
IE16.03.2022
LU16.03.2022
Former [2022/47]AL25.08.2021
AT25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
IT25.08.2021
LT25.08.2021
LV25.08.2021
MC25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
Former [2022/36]AL25.08.2021
AT25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
IT25.08.2021
LT25.08.2021
LV25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SI25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
Former [2022/29]AL25.08.2021
AT25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
Former [2022/25]AT25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SK25.08.2021
SM25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
Former [2022/24]AT25.08.2021
CZ25.08.2021
DK25.08.2021
EE25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
NL25.08.2021
PL25.08.2021
RO25.08.2021
RS25.08.2021
SE25.08.2021
SK25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
Former [2022/21]AT25.08.2021
DK25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
NL25.08.2021
PL25.08.2021
RS25.08.2021
SE25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
Former [2022/16]AT25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
NL25.08.2021
PL25.08.2021
RS25.08.2021
SE25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
Former [2022/10]AT25.08.2021
ES25.08.2021
FI25.08.2021
HR25.08.2021
LT25.08.2021
LV25.08.2021
PL25.08.2021
RS25.08.2021
SE25.08.2021
BG25.11.2021
NO25.11.2021
GR26.11.2021
IS25.12.2021
PT27.12.2021
Former [2022/09]AT25.08.2021
ES25.08.2021
FI25.08.2021
LT25.08.2021
RS25.08.2021
SE25.08.2021
BG25.11.2021
NO25.11.2021
PT27.12.2021
Former [2022/08]AT25.08.2021
ES25.08.2021
FI25.08.2021
LT25.08.2021
SE25.08.2021
BG25.11.2021
NO25.11.2021
Former [2022/07]AT25.08.2021
LT25.08.2021
NO25.11.2021
Cited inInternational search[A]WO8303830  (GRAY CHARLES RICHARDSON WHITE, et al) [A] 8,9* the whole document *;
 [X]WO0018965  (UNIV UTAH RES FOUND [US]) [X] 8-11,16 * page 29, line 28 - line 32; example 2 *;
 [XYI]CN102286473  (W WANG) [X] 1,2,16-18 * page 7, paragraph 61 - paragraph 62; claim 8 * [Y] 12-15 [I] 7,19,20;
 [XDYI]US2012258500  (CHENG MAN [US]) [XD] 3,4,7,16 * paragraphs [0145] , [ 157] - [0158] * * paragraph [0096]; example 1; claim 1 * [Y] 27-29 [I] 5,6,17,18,22-26,30;
 [I]  - BU YING ET AL, "Direct polymerase chain reaction (PCR) from human whole blood and filter-paper-dried blood by using a PCR buffer with a higher pH", ANALYTICAL BIOCHEMISTRY, (20080101), vol. 375, doi:10.1016/j.ab.2008.01.010, pages 370 - 372, XP055001023 [I] 1,2,7,16-20 * page 371, column r, paragraph 2 - paragraph 3 *

DOI:   http://dx.doi.org/10.1016/j.ab.2008.01.010
 [Y]  - ZELDIS J B ET AL, "DIRECT METHOD FOR DETECTING SMALL QUANTITIES OF HEPATITIS B VIRUS DNA IN SERUM AND PLASMA USING THE POLYMERASE CHAIN REACTION", JOURNAL OF CLINICAL INVESTIGATION, AMERICAN SOCIETY FOR CLINICAL INVESTIGATION, US, (19891101), vol. 84, no. 5, doi:10.1172/JCI114326, ISSN 0021-9738, pages 1503 - 1508, XP000616287 [Y] 12-15,27-29 * page 1506, column l, paragraph 1 *

DOI:   http://dx.doi.org/10.1172/JCI114326
 [A]  - L. A. LYAPINA ET AL, "Anticoagulant Effects of a Complex of High Molecular Weight Heparin and Arginine", BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, US, (20090301), vol. 147, no. 3, doi:10.1007/s10517-009-0501-7, ISSN 0007-4888, pages 328 - 330, XP055476981 [A] 3,4,21 * the whole document *

DOI:   http://dx.doi.org/10.1007/s10517-009-0501-7
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.